Abstract
Diabetes mellitus can cause alterations of skin homeostasis by both primary diabetes-induced changes of skin metabolism and by associated complications, such as vasculopathy and neuropathy resulting in various skin manifestations. Hyperglycemia-induced nonenzymatic glycation of structural and regulatory proteins plays a central role in the pathogenesis of diabetic complications. In addition, diabetic patients often exhibit altered keratinocyte functions due to the influence of insulin on keratinocyte proliferation, differentiation, and migration, resulting in impaired epidermal barrier function, delayed wound healing, and reduced stratum corneum hydration. This review describes the clinical aspects of the most common dermatologic skin manifestations that could be observed in patients with diabetes, which can be distinguished into specific cutaneous markers of diabetes and non-specific skin conditions associated with diabetes. The wide range of dermatologic conditions related to impaired glucose metabolism is important across multiple medical specialties to identify undiagnosed diabetes as early as possible and to better manage patients with known disease.
Similar content being viewed by others
References
Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol. 2010;37:146–55.
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013;149:84–91.
Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012;26:1203–11.
Bernstein JE, Levine LE, Medenica MM, Yung CW, Soltani K. Reduced threshold to suction-induced blister formation in insulin-dependent diabetics. J Am Acad Dermatol. 1983;8:790–1.
Buschke A. Vorstellung eines Falles von Sklero¨dem vor der Berliner Gesellschaft fu¨r Dermatologie. Arch Dermatol Syph. 1900;52:383.
Buzasi K, Sapi Z, Jermendy G. Acanthosis nigricans as a local cutaneous side effect of repeated human insulin injections. Diabetes Res Clin Pract. 2011;94:e34–6.
Consensus Development Conference on Diabetic Foot Wound Care: 7–8 Apr 1999, Boston, MA. American Diabetes Association. Diabetes Care 1999;22:1354–60.
Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol. 2013;169:783–93.
Durham LE, Kirkham BW, Taams LS. Contribution of the IL-17 pathway to psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2015;17:55.
Eberlein-Konig B, Vogel M, Katzer K, Hein R, Köhn FM, Ring J, Abeck D. Successful UVA1 phototherapy in a patient with scleredema adultorum. J Eur Acad Dermatol Venereol. 2005;19:203–4.
Edmonds ME, Foster AV. Diabetic foot ulcers. BMJ. 2006;332:407–10.
Erfurt-Berge C, Seitz AT, Rehse C, Wollina U, Schwede K, Renner R. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. Eur J Dermatol. 2012;22:770–5.
Evans AV, Atherton DJ. Recalcitrant ulcers in necrobiosis lipoidica diabeticorum healed by topical granulocyte-macrophage colony-stimulating factor. Br J Dermatol. 2002;147(5):1023.
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366:1736–43.
Feingold KR, Elias PM. Endocrine-skin interactions. Cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders, and diabetes. J Am Acad Dermatol. 1987;17:921–40.
Ferringer T, Miller F 3rd. Cutaneous manifestations of diabetes mellitus. Dermatol Clin. 2002;20:483–92.
Hu SW, Bevona C, Winterfield L, Qureshi AA, Li VW. Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case. Arch Dermatol. 2009;145:437–9.
Kakourou T, Psychou F, Voutetakis A, Xaidara A, Stefanaki K, Dacou-Voutetakis C. Low serum insulin values in children with multiple lesions of granuloma annulare: a prospective study. J Eur Acad Dermatol Venereol. 2005;19:30–4.
Khalid U, Hansen PR, Gislason GH, Lindhardsen J, Kristensen SL, Winther SA, Skov L, Torp-Pedersen C, Ahlehoff O. Psoriasis and new-onset diabetes. Diabetes Care. 2013;36:2402–7.
Kurihara Y, Kokuba H, Furue M. Case of diabetic scleredema: diagnostic value of magnetic resonance imaging. J Dermatol. 2011;3:693–6.
Larsen K, Jensen T, Karlsmark T, Holstein PE. Incidence of bullosis diabeticorum – a controversial cause of chronic foot ulceration. Int Wound J. 2008;5:591–6.
Lewerenz V, Ruzicka T. Scleredema adultorum associated with type 2 diabetes mellitus: a report of three cases. J Eur Acad Dermatol Venereol. 2007;21:560–1.
Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–55.
Meguerditchian C, Jacquet P, Béliard S, Benderitter T, Valéro R, Carsuzza F, Vialettes B. Scleredema adultorum of Buschke: an under recognized skin complication of diabetes. Diabetes Metab. 2006;32:481–4.
Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus a review. Endocrinol Metab Clin North Am. 2013;42:869–98.
Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5:194–222.
O’Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br J Dermatol. 1999;140:283–6.
Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.
Parker F. Xanthomas and hyperlipidemias. J Am Acad Dermatol. 1985;13:1–30.
Pavicic T, Korting HC. Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management. J Dtsch Dermatol Ges. 2006;4:935–41.
Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol. 1994;30:519–31.
Piaserico S, Zattra E, Linder D, Peserico A. Generalized granuloma annulare treated with methylaminolevulinate photodynamic therapy. Dermatology. 2009;218:282–4.
Rasi A, Soltani-Arabshahi R, Shahbazi N. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case-control study. Int J Dermatol. 2007;46:1155–9.
Rongioletti F, Kaiser F, Cinotti E, Metze D, Battistella M, Calzavara-Pinton PG, Damevska K, Girolomoni G, André J, Perrot JL, Kempf W, Cavelier-Balloy B. Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. J Eur Acad Dermatol Venereol. 2015;29:2399–404.
Rosmarin D, LaRaia A, Schlauder S, Gottlieb AB. Successful treatment of disseminated granuloma annulare with adalimumab. J Drugs Dermatol. 2009;8:169–71.
Sakaguchi M, Murata H, Aoyama Y, Hibino T, Putranto EW, Ruma IM, Inoue Y, Sakaguchi Y, Yamamoto K, Kinoshita R, Futami J, Kataoka K, Iwatsuki K, Huh NH. DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes. J Biol Chem. 2014;289:23389–402.
Seirafi H, Farsinejad K, Firooz A, Davoudi SM, Robati RM, Hoseini MS, Ehsani AH, Sadr B. Biophysical characteristics of skin in diabetes: a controlled study. J Eur Acad Dermatol Venereol. 2009;23:146–9.
Shall L, Millard L, Stevens A. Necrobiosis lipoidica: ‘the footprint not the footstep’. Br J Dermatol. 1990;123:47.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.
Wani AM, Hussain WM, Fatani MI, Qadmani A, Akhtar M, Maimani GA, Turkistani A, Bafaraj MG, Dairi KS. Eruptive xanthomas with Koebner phenomenon, type 1 diabetes mellitus, hypertriglyceridaemia and hypertension in a 41-year-old man. BMJ Case Rep 2009;2009. pii: bcr05.2009.1871.
Weisenseel P, Kuznetsov AV, Molin S, Ruzicka T, Berking C, Prinz JC. Photodynamic therapy for granuloma annulare: more than a shot in the dark. Dermatology. 2008;217:329–32.
Weisshaar E, Fleischer A, Bernhard J, Cropley T. Pruritus and dysesthesia. In: Bolognia JL, Jorizzo JL, Schaffer J, editors. Dermatology. New York: Elsevier Limited; 2012. p. 111–25.
Wertheimer E, Trebicz M, Eldar T, Gartsbein M, Nofeh-Moses S, Tennenbaum T. Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes. J Invest Dermatol. 2000;115:24–9.
Wilson TC, Snyder RJ, Southerland CC. Bullosis diabeticorum: is there a correlation between hyperglycemia and this symptomatology? Wounds. 2012;24:350–5.
Wu CY, Shieh JJ, Shen JL, Liu YY, Chang YT, Chen YJ. Association between antidiabetic drugs and psoriasis risk in diabetic patients: results from a nationwide nested case-control study in Taiwan. J Am Acad Dermatol. 2015;72:123–30.
Yamaoka H, Sasaki H, Yamasaki H, Ogawa K, Ohta T, Furuta H, Nishi M, Nanjo K. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care. 2010;33:150–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Gisondi, P., Fostini, A.C., Girolomoni, G. (2018). Diabetes and the Skin. In: Bonora, E., DeFronzo, R. (eds) Diabetes Complications, Comorbidities and Related Disorders. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-27316-7_14-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-27316-7_14-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27316-7
Online ISBN: 978-3-319-27316-7
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Diabetes and the Skin- Published:
- 25 August 2019
DOI: https://doi.org/10.1007/978-3-319-27316-7_14-2
-
Original
Diabetes and the Skin- Published:
- 07 March 2018
DOI: https://doi.org/10.1007/978-3-319-27316-7_14-1